PL3646867T3 - Kompozycja farmaceutyczna - Google Patents

Kompozycja farmaceutyczna

Info

Publication number
PL3646867T3
PL3646867T3 PL18825167.2T PL18825167T PL3646867T3 PL 3646867 T3 PL3646867 T3 PL 3646867T3 PL 18825167 T PL18825167 T PL 18825167T PL 3646867 T3 PL3646867 T3 PL 3646867T3
Authority
PL
Poland
Prior art keywords
pharmaceutical composition
pharmaceutical
composition
Prior art date
Application number
PL18825167.2T
Other languages
English (en)
Inventor
Shin Sugimoto
Akito Minamizono
Original Assignee
Kowa Company, Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kowa Company, Ltd. filed Critical Kowa Company, Ltd.
Publication of PL3646867T3 publication Critical patent/PL3646867T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • A61K9/2018Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42Oxazoles
    • A61K31/423Oxazoles condensed with carbocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38Cellulose; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1617Organic compounds, e.g. phospholipids, fats
    • A61K9/1623Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Diabetes (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Inorganic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biochemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
PL18825167.2T 2017-06-30 2018-06-29 Kompozycja farmaceutyczna PL3646867T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2017128695 2017-06-30
PCT/JP2018/024884 WO2019004449A1 (ja) 2017-06-30 2018-06-29 医薬組成物

Publications (1)

Publication Number Publication Date
PL3646867T3 true PL3646867T3 (pl) 2025-02-17

Family

ID=64742037

Family Applications (1)

Application Number Title Priority Date Filing Date
PL18825167.2T PL3646867T3 (pl) 2017-06-30 2018-06-29 Kompozycja farmaceutyczna

Country Status (12)

Country Link
US (1) US11406621B2 (pl)
EP (1) EP3646867B1 (pl)
JP (5) JP7104039B2 (pl)
KR (1) KR102726983B1 (pl)
CN (1) CN110831591A (pl)
ES (1) ES2989870T3 (pl)
HR (1) HRP20241476T1 (pl)
HU (1) HUE069648T2 (pl)
PL (1) PL3646867T3 (pl)
RS (1) RS66245B1 (pl)
SM (1) SMT202400478T1 (pl)
WO (1) WO2019004449A1 (pl)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019004449A1 (ja) 2017-06-30 2019-01-03 興和株式会社 医薬組成物
TWI829841B (zh) * 2018-12-27 2024-01-21 日商興和股份有限公司 醫藥品
JP2022013875A (ja) * 2020-06-30 2022-01-18 興和株式会社 医薬組成物
CN112402381B (zh) * 2020-11-19 2023-02-28 广州一品红制药有限公司 一种盐酸克林霉素棕榈酸酯颗粒组合物及其制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2004270538C1 (en) 2003-09-03 2010-01-14 Kowa Co., Ltd PPAR-activating compound and pharmaceutical composition containing same
ZA200601272B (en) * 2003-09-03 2007-04-25 Kowa Co PPAR-activating compound and pharmaceutical composition containing same
EA024873B1 (ru) 2012-09-27 2016-10-31 Кова Компани, Лтд. Терапевтическое средство при дислипидемии
TWI696462B (zh) 2013-07-10 2020-06-21 日商興和股份有限公司 非酒精性脂肪性肝疾病治療劑
CH712649A1 (fr) * 2016-07-05 2018-01-15 Hemo Plus Sàrl Centre de traitement pour des soins par hémodialyse.
WO2019004449A1 (ja) * 2017-06-30 2019-01-03 興和株式会社 医薬組成物

Also Published As

Publication number Publication date
KR102726983B1 (ko) 2024-11-07
CN110831591A (zh) 2020-02-21
HRP20241476T1 (hr) 2025-01-03
JP2022082819A (ja) 2022-06-02
ES2989870T3 (es) 2024-11-28
JP2024045760A (ja) 2024-04-02
JPWO2019004449A1 (ja) 2020-04-30
EP3646867A1 (en) 2020-05-06
JP2019011324A (ja) 2019-01-24
HUE069648T2 (hu) 2025-03-28
EP3646867B1 (en) 2024-10-09
EP3646867A4 (en) 2021-03-24
US20200155514A1 (en) 2020-05-21
SMT202400478T1 (it) 2025-01-14
EP3646867C0 (en) 2024-10-09
JP2026015525A (ja) 2026-01-29
WO2019004449A1 (ja) 2019-01-03
KR20200019903A (ko) 2020-02-25
JP7104039B2 (ja) 2022-07-20
RS66245B1 (sr) 2024-12-31
US11406621B2 (en) 2022-08-09

Similar Documents

Publication Publication Date Title
IL265260B (en) pharmaceutical preparations
IL265360B (en) Pharmaceutical composition
IL271986A (en) pharmaceutical preparation
IL269061A (en) A pharmaceutical preparation containing Selexifag
IL262654A (en) Pharmacy preparation
IL265349A (en) Pharmaceutical composition
GB201712159D0 (en) Pharmaceutical composition
GB201705303D0 (en) Pharmaceutical compositions
PL3583943T3 (pl) Kompozycja farmaceutyczna
GB201705304D0 (en) Pharmaceutical compositions
IL272419A (en) Pharmaceutical composition
GB201719447D0 (en) Pharmaceutical composition
GB201705306D0 (en) Pharmaceutical compositions
GB201705305D0 (en) Pharmaceutical compositions
PL3646867T3 (pl) Kompozycja farmaceutyczna
PL3454838T3 (pl) Kompozycja farmaceutyczna
GB201615917D0 (en) Pharmaceutical composition
GB201615914D0 (en) Pharmaceutical composition
IL271513A (en) Innovative pharmaceutical composition
GB201615910D0 (en) Pharmaceutical composition
IL265436B (en) Pharmacy preparation
GB201620519D0 (en) Pharmaceutical composition
IL265428A (en) Pharmaceutical composition
GB201708328D0 (en) Pharmaceutical composition
GB201708329D0 (en) Pharmaceutical composition